Overview
- The acquisition consists of $1.065 billion in IonQ common stock and $10 million in cash and is expected to close in the second half of 2025.
- The merged entity will target quantum systems with 256 physical qubits by 2026, more than 10,000 qubits by 2027, and two million qubits by 2030 at logical accuracies above 99.99%.
- Oxford Ionics founders Dr. Chris Ballance and Dr. Tom Harty are set to remain with IonQ and lead expansion of its quantum development hub in Oxford.
- Both companies were selected for DARPA’s Quantum Benchmarking Initiative earlier this year, underscoring their role in advancing fault-tolerant architectures.
- IonQ’s collaborations with AstraZeneca, Amazon Web Services, and Nvidia demonstrated a hybrid quantum-classical workflow that cut a key drug discovery simulation from months to days.